Life-Threatening Anaphylaxis due to Cerebrolysin® [PDF]
In this case report, we describe a well-documented, severe anaphylactic reaction after intravenous administration of cerebrolysin, a neurotrophic agent derived from highly purified porcine brain tissue, consisting of peptides and free amino acids ...
Helmut Trimmel +2 more
doaj +5 more sources
Is Cerebrolysin Useful in Psychiatry Disorders? [PDF]
Background/Objectives: Cerebrolysin is a well-known mixture of peptides that has been used for many years, primarily in patients with neurological disorders.
Szymon Florek +3 more
doaj +3 more sources
Cerebrolysin in Patients Diagnosed with Subarachnoid Hemorrhage—The Results of an Observational Cohort Study [PDF]
Background: Subarachnoid hemorrhage (SAH) is associated with high mortality and a high level of disability. Progress in surgical and endovascular techniques has lowered the mortality rate in patients with SAH.
Klaudyna Kojder +6 more
doaj +2 more sources
Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis [PDF]
IntroductionSevere traumatic brain injury (sTBI) remains a major cause of long-term disability and mortality worldwide. Beyond the initial mechanical damage, a cascade of secondary injuries involving neuroinflammation, oxidative stress, and ...
Philipp Schlager +8 more
doaj +2 more sources
Cerebrolysin as an adjuvant therapy after mechanical thrombectomy in large vessel occlusion cardioembolic stroke: a propensity score matching analysis [PDF]
IntroductionEndovascular recanalization therapy has demonstrated considerable efficacy in the treatment of acute ischemic stroke (AIS). However, not all patients appear to benefit on the long term from this therapy.
Ahmed ElBassiouny +6 more
doaj +2 more sources
Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study. [PDF]
This study hypothesized that Cerebrolysin, a multimodal neuroprotective agent, enhances the efficacy and safety of mechanical thrombectomy (MT) in both acute ischemic stroke (AIS) and recovery stroke phases in selected patients with good collateral ...
Staszewski J +12 more
europepmc +3 more sources
Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study [PDF]
Background and Objectives: Acute ischemic stroke is a major cause of disability and mortality. Cerebrolysin, a neuropeptide with neuroprotective and neurotrophic properties, may enhance post-stroke recovery.
Geetha Kandasamy +6 more
doaj +2 more sources
Using of cerebrolysin in patients with epilepsy
Objective: to assess the efficiency and tolerability of cerebrolysin in patients with epilepsy.Materials and methods. Sixty six epileptic patients with low Montreal Cognitive Assessment results (less than 26 scores) were studied. The examination included
A. S. Kotov
doaj +3 more sources
Cerebrolysin for acute ischaemic stroke [PDF]
Background: Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from pigs' brain tissue which has proposed neuroprotective and neurotrophic properties. It is widely used in the treatment of acute ischaemic stroke in Russia and China. Objectives: To assess the benefits and risks of cerebrolysin for treating acute ischaemic
Lilia E, Ziganshina +2 more
openaire +8 more sources
Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation
Hair graying, a prototypical sign of human aging, is a progressive loss of pigmentation from growing hair shafts caused by disease and as a side effect of medications.
Gustavo Villarreal-Reyna +8 more
doaj +1 more source

